# Systematic Treatment and Monitoring Status Protocol

## Problem Statement

**Issue Identified**: Lisa Anderson (MRN000944, G3b-A2, Treatment Status: Active) received AI recommendations stating:
- "Patient not currently on CKD treatment - consider initiating therapy"
- "Consider initiating CKD treatment per clinical guidelines"

This is **INCORRECT** because the patient is **already on active CKD treatment**.

**Root Cause**: AI not properly checking or respecting the treatment status field before making recommendations, leading to contradictory and potentially confusing advice for clinicians.

---

## Critical Requirements

### 1. Treatment Status MUST Be Verified FIRST

Before ANY treatment recommendation, the AI MUST:

1. **Read** the `Treatment Status` field from Patient Context
2. **Determine** if patient is:
   - `Active (...)` ‚Üí Patient IS currently on treatment
   - `NOT ON TREATMENT` ‚Üí Patient is NOT currently on treatment
3. **Base ALL recommendations** on this status

### 2. Monitoring Status MUST Be Verified FIRST

Before ANY monitoring recommendation, the AI MUST:

1. **Read** the `Monitoring Status` field from Patient Context
2. **Determine** if patient is:
   - `Active (...)` ‚Üí Patient IS currently being monitored at home
   - `NOT ON MONITORING` ‚Üí Patient is NOT currently on home monitoring
3. **Base ALL recommendations** on this status

### 3. Recommendations MUST Match Current Status

**Golden Rule**: The AI's recommendations must be **logically consistent** with the current treatment/monitoring status.

| Current Status | ‚úÖ CORRECT Recommendation | ‚ùå WRONG Recommendation |
|----------------|---------------------------|-------------------------|
| Treatment: Active | "Continue current CKD treatment", "Optimize therapy", "Adjust dosing" | "Initiate treatment", "Consider starting therapy" |
| Treatment: NOT ON TREATMENT | "Initiate RAS inhibitor", "Start SGLT2 inhibitor" | "Continue current treatment", "Maintain therapy" |
| Monitoring: Active | "Continue Minuteful Kidney monitoring", "Maintain home testing schedule" | "Initiate home monitoring", "Consider starting Minuteful Kidney" |
| Monitoring: NOT ON MONITORING | "Initiate Minuteful Kidney home monitoring (Monthly)" | "Continue home monitoring", "Maintain current testing" |

---

## Systematic Verification Checklist

Every AI analysis MUST follow this checklist:

### Step 1: Status Verification (MANDATORY FIRST STEP)

- [ ] Read `Treatment Status` field from Patient Context
- [ ] Read `Monitoring Status` field from Patient Context
- [ ] Determine current state:
  - Treatment: Active OR Not on Treatment
  - Monitoring: Active OR Not on Monitoring
- [ ] Log status to internal reasoning: "Patient treatment status: [Active/Not on Treatment]"

### Step 2: Biomarker Analysis

- [ ] Compare current vs previous eGFR (absolute change, percentage, trend)
- [ ] Compare current vs previous uACR (absolute change, percentage, trend)
- [ ] Assess health state change (e.g., G3a‚ÜíG3b, A1‚ÜíA2)
- [ ] Determine if patient is stable, improving, or worsening

### Step 3: Treatment Recommendation Logic

#### IF Treatment Status = Active:

- [ ] Check if patient is stable/improving:
  - ‚úÖ "Continue current CKD treatment - appears effective"
  - ‚úÖ "Maintain current regimen (RAS inhibitor + SGLT2i)"
  - ‚úÖ "Current treatment shows benefit - kidney function stable"

- [ ] Check if patient is worsening:
  - ‚úÖ "Optimize current CKD therapy - consider dose adjustment"
  - ‚úÖ "Treatment optimization needed - eGFR declining despite therapy"
  - ‚úÖ "Add additional disease-modifying agent (e.g., SGLT2i if not on one)"
  - ‚úÖ "Nephrology referral for treatment intensification"

- [ ] **NEVER** say:
  - ‚ùå "Initiate CKD treatment" (already on treatment!)
  - ‚ùå "Consider starting therapy" (already started!)
  - ‚ùå "Patient not currently on treatment" (contradicts status!)

#### IF Treatment Status = NOT ON TREATMENT:

- [ ] Check Phase 3 Treatment Decision Analysis for recommendations
- [ ] If Phase 3 shows STRONG/MODERATE indication:
  - ‚úÖ "Initiate RAS inhibitor therapy (STRONG indication - KDIGO Grade 1A)"
  - ‚úÖ "Start SGLT2 inhibitor (Jardiance) - EMPA-KIDNEY trial showed 28% risk reduction"
  - ‚úÖ Include specific evidence and reasoning from Phase 3

- [ ] If CKD Stage 3+ without Phase 3 analysis:
  - ‚úÖ "Initiate disease-modifying CKD therapy per KDIGO guidelines"
  - ‚úÖ "Start nephroprotective medications - RAS inhibitor and/or SGLT2i"

- [ ] If worsening kidney function:
  - ‚úÖ "URGENT: Initiate CKD treatment immediately - progressive decline detected"
  - ‚úÖ "Recommend immediate nephrology referral and treatment initiation"

- [ ] **NEVER** say:
  - ‚ùå "Continue current treatment" (no treatment to continue!)
  - ‚ùå "Optimize therapy" (no therapy to optimize!)
  - ‚ùå "Maintain current regimen" (no regimen exists!)

### Step 4: Monitoring Recommendation Logic

#### IF Monitoring Status = Active:

- [ ] Acknowledge home monitoring is active:
  - ‚úÖ "Continue Minuteful Kidney home monitoring - provides valuable trend data"
  - ‚úÖ "Maintain current home testing schedule (Monthly/Bi-weekly/Weekly)"
  - ‚úÖ "Home monitoring active - review recent uACR trends from device"

- [ ] If monitoring frequency needs adjustment:
  - ‚úÖ "Increase Minuteful Kidney frequency to Weekly (worsening kidney function)"
  - ‚úÖ "Consider more frequent home testing given recent eGFR decline"

- [ ] **NEVER** say:
  - ‚ùå "Initiate home monitoring" (already initiated!)
  - ‚ùå "Consider starting Minuteful Kidney" (already active!)

#### IF Monitoring Status = NOT ON MONITORING:

- [ ] Check Phase 3 recommendations for Minuteful Kidney
- [ ] If Phase 3 shows "Recommended: YES":
  - ‚úÖ "Initiate Minuteful Kidney home monitoring (Monthly frequency)"
  - ‚úÖ Include rationale and adherence benefits from Phase 3
  - ‚úÖ "Start at-home uACR testing between clinic visits"

- [ ] If CKD patient without Phase 3 recommendation:
  - ‚úÖ "Evaluate patient for Minuteful Kidney home monitoring"
  - ‚úÖ "Consider at-home uACR monitoring for trend data"

- [ ] **NEVER** say:
  - ‚ùå "Continue home monitoring" (not started yet!)
  - ‚ùå "Maintain Minuteful Kidney testing" (not active!)

### Step 5: Follow-Up Timing

- [ ] Specify exact timeframe based on KDIGO risk level (see `/docs/FOLLOW_UP_TIMING_MATRIX.md`)
- [ ] Include risk justification (RED/ORANGE/YELLOW/GREEN or High/Moderate/Low)
- [ ] List specific tests to order
- [ ] **NEVER** use vague phrases like "follow up as scheduled"

### Step 6: Final Validation

Before generating final output:

- [ ] Re-read treatment status - does my recommendation match?
- [ ] Re-read monitoring status - does my recommendation match?
- [ ] Check for contradictions: Am I saying "initiate" for someone already treated?
- [ ] Check for vague timing: Did I specify exact follow-up interval?
- [ ] Check for specificity: Did I name specific medications/frequencies?

---

## Implementation in AI Prompt

### Current Prompt Structure

The AI prompt already includes treatment/monitoring status at line 396-397:

```
- Treatment Status: ${context.treatmentActive ? `Active (${context.treatmentType || 'Unknown'})` : 'NOT ON TREATMENT'}
- Monitoring Status: ${context.monitoringActive ? `Active${context.monitoringDevice ? ` (${context.monitoringDevice})` : ''}` : 'NOT ON MONITORING'}
```

And instructions at lines 426-453 about checking status first.

### Enhancement Needed

The AI instructions need to be **MORE PROMINENT** and **IMPOSSIBLE TO MISS**. Proposed enhancement:

```markdown
**üö® CRITICAL: STATUS VERIFICATION REQUIRED BEFORE ALL RECOMMENDATIONS üö®**

STEP 1: LOOK AT THESE TWO FIELDS IN THE "PATIENT CONTEXT" SECTION ABOVE:
========================================================================
- Treatment Status: [Will show "Active (...)" OR "NOT ON TREATMENT"]
- Monitoring Status: [Will show "Active (...)" OR "NOT ON MONITORING"]

STEP 2: INTERNAL REASONING (Required):
========================================================================
Before making ANY recommendation, you MUST state internally:
- "Patient treatment status: [Active/Not on Treatment]"
- "Patient monitoring status: [Active/Not on Monitoring]"

STEP 3: APPLY RECOMMENDATION LOGIC:
========================================================================
IF Treatment Status = "Active (...)":
  ‚Üí Patient IS on treatment
  ‚Üí Use: "Continue current treatment", "Optimize therapy", "Adjust regimen"
  ‚Üí NEVER use: "Initiate treatment", "Start therapy", "Consider starting"

IF Treatment Status = "NOT ON TREATMENT":
  ‚Üí Patient is NOT on treatment
  ‚Üí Use: "Initiate RAS inhibitor", "Start SGLT2 inhibitor"
  ‚Üí NEVER use: "Continue treatment", "Maintain therapy", "Optimize current regimen"

IF Monitoring Status = "Active (...)":
  ‚Üí Patient IS being monitored at home
  ‚Üí Use: "Continue home monitoring", "Maintain Minuteful Kidney testing"
  ‚Üí NEVER use: "Initiate home monitoring", "Start Minuteful Kidney"

IF Monitoring Status = "NOT ON MONITORING":
  ‚Üí Patient is NOT being monitored at home
  ‚Üí Use: "Initiate Minuteful Kidney monitoring", "Start at-home testing"
  ‚Üí NEVER use: "Continue home monitoring", "Maintain testing schedule"

**VALIDATION**: Before submitting your response, ask yourself:
- "Does my treatment recommendation match the treatment status?" (YES/NO)
- "Does my monitoring recommendation match the monitoring status?" (YES/NO)
- If either is NO, REVISE your recommendations!
```

---

## Example Cases

### Case 1: Lisa Anderson (G3b-A2, Treatment Status: Active)

**Patient Context**:
- Treatment Status: Active (RAS Inhibitor + SGLT2i)
- Monitoring Status: Active (Minuteful Kidney Kit)
- Current: eGFR 38 mL/min/1.73m¬≤, uACR 95 mg/g
- Previous: eGFR 40 mL/min/1.73m¬≤, uACR 90 mg/g
- Change: eGFR declined 2 units, uACR increased 5.6%

**‚úÖ CORRECT AI Response**:
```json
{
  "commentText": "Lab update shows mild kidney function decline despite active treatment.",
  "clinicalSummary": "Patient on active CKD treatment (RAS inhibitor + SGLT2i). eGFR declined from 40 to 38 mL/min/1.73m¬≤ (-5%). uACR increased from 90 to 95 mg/g (+5.6%). G3b-A2 classification maintained (very high risk per KDIGO). Current treatment shows partial benefit (uACR relatively stable), but declining eGFR suggests need for treatment optimization.",
  "keyChanges": [
    "eGFR declined from 40 to 38 mL/min/1.73m¬≤ (-5% decline)",
    "uACR increased from 90 to 95 mg/g (+5.6% increase)",
    "Health state remains G3b-A2 (very high risk)"
  ],
  "recommendedActions": [
    "Continue current CKD treatment (RAS inhibitor + SGLT2i) - shows partial benefit with stable albuminuria",
    "Optimize therapy - consider dose adjustment of current medications given declining eGFR",
    "Continue Minuteful Kidney home monitoring (Active) - review recent uACR trends from device",
    "Schedule follow-up in 1-3 months (very high risk - RED per KDIGO). Next labs: comprehensive metabolic panel, eGFR, creatinine, uACR, electrolytes, CBC",
    "Nephrology referral for treatment optimization if eGFR continues to decline"
  ],
  "severity": "warning",
  "concernLevel": "moderate"
}
```

**‚ùå WRONG AI Response** (What happened):
```json
{
  "commentText": "Routine lab update completed.",
  "clinicalSummary": "Routine lab update completed. Patient not currently on CKD treatment - consider initiating therapy.",
  "keyChanges": ["Lab values updated"],
  "recommendedActions": [
    "Consider initiating CKD treatment per clinical guidelines",
    "Follow up as scheduled"
  ],
  "severity": "info",
  "concernLevel": "none"
}
```

**Problems with WRONG response**:
1. ‚ùå Says "not currently on CKD treatment" when Treatment Status = Active
2. ‚ùå Recommends "initiating" treatment when already active
3. ‚ùå Vague "follow up as scheduled" without specific timeframe
4. ‚ùå No acknowledgment of declining eGFR
5. ‚ùå No acknowledgment of active home monitoring
6. ‚ùå Severity downgraded to "info" when should be "warning" for declining kidney function

---

### Case 2: Patient NOT on Treatment (Correct Initiation)

**Patient Context**:
- Treatment Status: NOT ON TREATMENT
- Monitoring Status: NOT ON MONITORING
- Health State: G3a-A2 (Moderate CKD, moderate albuminuria)
- Phase 3: RAS Inhibitor STRONG indication, Minuteful Kidney recommended Monthly

**‚úÖ CORRECT AI Response**:
```json
{
  "commentText": "New CKD diagnosis - treatment initiation recommended.",
  "clinicalSummary": "Patient has Moderate CKD (G3a-A2) and is NOT currently on treatment. Phase 3 analysis shows STRONG indication for RAS inhibitor therapy (KDIGO Grade 1A - proven 30-40% proteinuria reduction). Minuteful Kidney home monitoring recommended for monthly at-home uACR tracking.",
  "keyChanges": [
    "Transitioned to Moderate CKD (G3a-A2)",
    "uACR 85 mg/g - moderate albuminuria (A2 category)",
    "Treatment not yet initiated"
  ],
  "recommendedActions": [
    "Initiate RAS inhibitor therapy (lisinopril or losartan) - STRONG indication (KDIGO Grade 1A) for albuminuria reduction",
    "Safety labs in 1-2 weeks after starting RAS inhibitor: check potassium and creatinine",
    "Initiate Minuteful Kidney home monitoring (Monthly frequency) for at-home uACR tracking between clinic visits",
    "Schedule follow-up in 6-12 months after treatment initiation (moderate risk - YELLOW per KDIGO)",
    "Monitor blood pressure - target <130/80 mmHg for kidney protection"
  ],
  "severity": "warning",
  "concernLevel": "moderate"
}
```

---

## Quality Assurance Checks

### Automated Validation (Recommended Enhancement)

Add server-side validation logic to catch contradictions:

```typescript
function validateAIRecommendations(
  treatmentActive: boolean,
  monitoringActive: boolean,
  recommendations: string[]
): { valid: boolean; errors: string[] } {
  const errors: string[] = [];

  // Check for treatment contradictions
  if (treatmentActive) {
    const hasInitiatePhrase = recommendations.some(r =>
      /initiat(e|ing) (ckd )?treatment/i.test(r) ||
      /start(ing)? therapy/i.test(r) ||
      /consider starting/i.test(r)
    );
    if (hasInitiatePhrase) {
      errors.push('AI recommended initiating treatment for patient already on active treatment');
    }
  } else {
    const hasContinuePhrase = recommendations.some(r =>
      /continue (current )?treatment/i.test(r) ||
      /maintain (current )?therapy/i.test(r) ||
      /optimize (current )?therapy/i.test(r)
    );
    if (hasContinuePhrase) {
      errors.push('AI recommended continuing treatment for patient not on treatment');
    }
  }

  // Check for monitoring contradictions
  if (monitoringActive) {
    const hasInitiateMonitoring = recommendations.some(r =>
      /initiat(e|ing) (home )?monitoring/i.test(r) ||
      /start(ing)? minuteful kidney/i.test(r)
    );
    if (hasInitiateMonitoring) {
      errors.push('AI recommended initiating monitoring for patient already on active monitoring');
    }
  } else {
    const hasContinueMonitoring = recommendations.some(r =>
      /continue (home )?monitoring/i.test(r) ||
      /maintain minuteful kidney/i.test(r)
    );
    if (hasContinueMonitoring) {
      errors.push('AI recommended continuing monitoring for patient not on monitoring');
    }
  }

  // Check for vague follow-up timing
  const hasVagueTiming = recommendations.some(r =>
    /follow up as scheduled/i.test(r) && !/\d+\s+(month|week|year)/i.test(r)
  );
  if (hasVagueTiming) {
    errors.push('AI used vague follow-up timing without specific interval');
  }

  return {
    valid: errors.length === 0,
    errors
  };
}
```

### Manual Review Checklist

For each AI analysis, reviewers should check:

- [ ] Treatment recommendation matches treatment status (Active vs Not on Treatment)
- [ ] Monitoring recommendation matches monitoring status (Active vs Not on Monitoring)
- [ ] Specific medications named (not "consider therapy" - which drugs?)
- [ ] Specific follow-up timing (not "as scheduled" - when exactly?)
- [ ] Biomarker trends quantified (not "stable" - by how much?)
- [ ] Severity appropriate for clinical situation
- [ ] No contradictory statements in summary vs recommendations

---

## Training and Documentation

### For AI Prompt Engineers

- Always include treatment/monitoring status in patient context
- Make status verification instructions PROMINENT (use emojis, caps, separators)
- Provide explicit if-then logic for each status combination
- Include validation step at end of prompt
- Test with both active and not-on-treatment scenarios

### For Clinical Reviewers

- Check AI recommendations against patient status in UI
- Flag any contradictions immediately
- Review Phase 3 analysis to ensure AI incorporated evidence
- Verify specific timing/medications are provided

### For Developers

- Ensure `treatmentActive` and `monitoringActive` fields are correctly populated from database
- Implement automated validation checks (see above)
- Log AI analysis with status snapshot for audit trail
- Add UI warning if status changes after AI analysis generated

---

## Success Metrics

- **100% of AI analyses** match treatment status (no "initiate" for active, no "continue" for not-on-treatment)
- **100% of AI analyses** match monitoring status (no "initiate" for active, no "continue" for not-on-monitoring)
- **100% of AI analyses** include specific follow-up timing (no "as scheduled")
- **0 contradictory recommendations** flagged in quality review
- **<1% false positive rate** on automated validation checks

---

## Escalation Protocol

If contradiction is detected:

1. **Automated Detection**: Server validation catches contradiction before saving to database
2. **Flag for Review**: Mark analysis as "Needs Review" with specific error message
3. **Retry AI Analysis**: Regenerate with enhanced prompt if validation fails
4. **Manual Override**: Allow clinician to manually edit if AI repeatedly fails
5. **Log for Improvement**: Track all validation failures for prompt engineering refinement

---

This protocol ensures every AI recommendation is **logically consistent, clinically appropriate, and actionable** based on the patient's current treatment and monitoring status.
